House investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drug
Sarah Silbiger/Getty Images, FILE (WASHINGTON) --- A congressional investigation into the Food and Drug Administration's review process for an Alzheimer's treatment found that the…
